Many promising enzymes and proteins never reach commercial production because they are difficult to express efficiently.
Low recombinant expression can result in:
Neoncorte Bio develops AI-engineered proteins optimized for improved recombinant expression, helping organizations move from laboratory discovery to scalable manufacturing.